STZ - Constellation Brands, Inc.
NYSE
->
Consumer Defensive
->
Beverages—Wineries & Distilleries
Victor,
United States
Type: Equity
STZ price evolution
STZ
| (in millions $) | 31 Jan 2025 | 1 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $73.8 | $152.4 | ||
| Short term investments | ||||
| Net receivables | $871.3 | $893.9 | $832.8 | |
| Inventory | $2098.6 | $2127 | $2078.3 | |
| Total current assets | $3646.8 | $3828.4 | $3729.5 | |
| Long term investments | $170.6 | |||
| Property, plant & equipment | $7898.8 | $8298 | $8055.2 | |
| Goodwill & intangible assets | $10716.9 | $10712 | ||
| Total noncurrent assets | $22231.7 | $21962.2 | ||
| Total investments | $170.6 | |||
| Total assets | $23079.1 | $26060.1 | $25691.7 | |
| Current liabilities | ||||
| Accounts payable | $1099.4 | $1139.3 | $1107.1 | |
| Deferred revenue | ||||
| Short long term debt | $1199.4 | $1198.2 | ||
| Total current liabilities | $2913.8 | $3122.2 | $3141.7 | |
| Long term debt | $10683.6 | $10682.9 | $10681.1 | |
| Total noncurrent liabilities | $12366 | $12485.4 | ||
| Total debt | $11882.3 | $11879.3 | ||
| Total liabilities | $15208.3 | $15488.2 | $15627.1 | |
| Shareholders' equity | ||||
| Retained earnings | $12727.2 | $14109.5 | $13417.2 | |
| Other shareholder equity | -$427.2 | $367.8 | $376.8 | |
| Total shareholder equity | $10251.8 | $9743.1 | ||
| (in millions $) | 31 Jan 2025 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $152.4 | $133.5 | $199.4 | $460.6 |
| Short term investments | ||||
| Net receivables | $832.8 | $901.6 | $899 | $785.3 |
| Inventory | $2078.3 | $1898.7 | $1573.2 | $1291.1 |
| Total current assets | $3729.5 | $3496.1 | $3329.7 | $3044.5 |
| Long term investments | $170.6 | $756.5 | $2880.1 | $4606.5 |
| Property, plant & equipment | $8055.2 | $6865.2 | $6059.6 | $5821.6 |
| Goodwill & intangible assets | $10712 | $10653.5 | $10617.6 | $10525.6 |
| Total noncurrent assets | $21962.2 | $21166.2 | $22526.1 | $24060.3 |
| Total investments | $170.6 | $756.5 | $2880.1 | $4606.5 |
| Total assets | $25691.7 | $24662.3 | $25855.8 | $27104.8 |
| Current liabilities | ||||
| Accounts payable | $1107.1 | $941.5 | $899.2 | $460 |
| Deferred revenue | ||||
| Short long term debt | $1198.2 | $1174.8 | $928.3 | $29.2 |
| Total current liabilities | $3141.7 | $2968.3 | $2698.8 | $1269.1 |
| Long term debt | $10681.1 | $11286.5 | $9488.2 | $10413.1 |
| Total noncurrent liabilities | $12485.4 | $12960.1 | $11109.2 | $11906.6 |
| Total debt | $11879.3 | $12461.3 | $10416.5 | $10442.3 |
| Total liabilities | $15627.1 | $15928.4 | $13808 | $13175.7 |
| Shareholders' equity | ||||
| Retained earnings | $13417.2 | $12343.9 | $14505.4 | $15117.8 |
| Other shareholder equity | $376.8 | $28.5 | -$412.7 | -$335.5 |
| Total shareholder equity | $9743.1 | $8413.6 | $11731.9 | $13598.9 |
| (in millions $) | 30 Jul 2025 | 31 Jan 2025 | 1 Oct 2024 | 30 Jun 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2918.9 | $2661.8 | ||
| Cost of revenue | $1258 | |||
| Gross Profit | $1513.1 | $1403.8 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $462.2 | |||
| Total operating expenses | $461.3 | $462.2 | ||
| Operating income | $941.6 | |||
| Income from continuing operations | ||||
| EBIT | $1007.8 | |||
| Income tax expense | -$152.2 | $28 | ||
| Interest expense | -$105.2 | $102.8 | ||
| Net income | ||||
| Net income | -$1199 | $877 | ||
| Income (for common shares) | $877 | |||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $9961.8 | $9452.6 | $8820.7 | $8614.9 |
| Cost of revenue | $4944.3 | $4683.6 | $4113.4 | $4148.9 |
| Gross Profit | $5017.5 | $4769 | $4707.3 | $4466 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1847.8 | $1926.1 | $1711.4 | $1665.1 |
| Total operating expenses | $1847.8 | $1926.1 | $2377.3 | $1689.1 |
| Operating income | $3169.7 | $2842.9 | $2330 | $2776.9 |
| Income from continuing operations | ||||
| EBIT | $2619.4 | $749.8 | $625.4 | $2894.8 |
| Income tax expense | $456.6 | $422.1 | $309.4 | $511.1 |
| Interest expense | $435.4 | $398.7 | $356.4 | $385.7 |
| Net income | ||||
| Net income | $1727.4 | -$71 | -$40.4 | $1998 |
| Income (for common shares) | $1727.4 | -$71 | -$40.4 | $1998 |
| (in millions $) | 1 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $877 | $392.4 | $509.1 | |
| Operating activities | ||||
| Depreciation | $140.7 | $134.5 | $127.7 | |
| Business acquisitions & disposals | -$13 | -$7 | ||
| Stock-based compensation | $17.3 | $14.1 | $17 | |
| Total cash flows from operations | $690.5 | $433.2 | $724.8 | |
| Investing activities | ||||
| Capital expenditures | -$362.4 | -$357.1 | -$322.9 | |
| Investments | $0.3 | |||
| Total cash flows from investing | -$857.6 | -$377.4 | -$356 | -$329 |
| Financing activities | ||||
| Dividends paid | -$368.6 | -$185.3 | -$162.7 | -$163.5 |
| Sale and purchase of stock | -$175.3 | $15.5 | -$211.9 | |
| Net borrowings | -$0.4 | $177.5 | -$10.9 | |
| Total cash flows from financing | -$1104 | -$393 | -$2.2 | -$400 |
| Effect of exchange rate | $1.5 | $1.3 | -$1.3 | -$0.4 |
| Change in cash and equivalents | -$87.8 | -$78.6 | $73.7 | -$4.6 |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $1727.4 | -$71 | -$40.4 | $1998 |
| Operating activities | ||||
| Depreciation | $519.2 | $473.1 | $419.2 | $377.1 |
| Business acquisitions & disposals | -$36.7 | $28.8 | -$85.5 | $757.2 |
| Stock-based compensation | $63.6 | $68.5 | $44.9 | $63 |
| Total cash flows from operations | $2780 | $2756.9 | $2705.4 | $2806.5 |
| Investing activities | ||||
| Capital expenditures | -$1247.2 | -$1028.7 | -$1022.7 | -$845.7 |
| Investments | $0.3 | $74.4 | ||
| Total cash flows from investing | -$1285.9 | -$999.4 | -$1035.8 | -$87.9 |
| Financing activities | ||||
| Dividends paid | -$653.8 | -$573 | -$575 | |
| Sale and purchase of stock | -$145.2 | -$1212.9 | $58.9 | |
| Net borrowings | -$596.9 | -$81.3 | -$1787.8 | |
| Total cash flows from financing | -$1474.6 | -$1929.5 | -$2346.6 | |
| Effect of exchange rate | -$0.6 | -$1.3 | $7.2 | |
| Change in cash and equivalents | $18.9 | -$261.2 | $379.2 | |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.60 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |